TY - JOUR
T1 - Feasibility of implantable cardioverter defibrillator use in elderly patients
T2 - A case series of octogenarians
AU - Noseworthy, Peter A.
AU - Lashevsky, Ilan
AU - Dorian, Paul
AU - Greene, Mary
AU - Cvitkovic, Suzan
AU - Newman, David
PY - 2004/3
Y1 - 2004/3
N2 - This article addresses the feasibility and safety of ICD therapy in patients >80 years of age. Recent trials have expanded the indication for ICD implantation to include an increasing number and variety of patients. The feasibility of ICD implantation in elderly patients has not been adequately studied. A prospectively collected single center ICD database was analyzed to assess the safety and feasibility of ICD implantation in elderly patients. Patients were divided based on age into two groups (group 1: 70-79 years of age, n = 183; group 2: ≥80 years of age, n = 29). The two groups were similar in gender distribution, NYHA class, and indication for implantation. The actuarial survival was not significantly different between groups 1 and 2 (P > 0.05; primary endpoint), with a 1-year survival of 91% and 93% in groups 1 and 2, respectively, (P = NS). The complication rates at the time of ICD implantation were similar in groups 1 and 2 (6.6% and 13.1%, respectively, P = 0.16). Age alone may not be sufficient criteria to exclude ICD implantation. The current consensus guidelines for ICD implantation appear to be generalizable to treating octogenarians who are otherwise medically fit.
AB - This article addresses the feasibility and safety of ICD therapy in patients >80 years of age. Recent trials have expanded the indication for ICD implantation to include an increasing number and variety of patients. The feasibility of ICD implantation in elderly patients has not been adequately studied. A prospectively collected single center ICD database was analyzed to assess the safety and feasibility of ICD implantation in elderly patients. Patients were divided based on age into two groups (group 1: 70-79 years of age, n = 183; group 2: ≥80 years of age, n = 29). The two groups were similar in gender distribution, NYHA class, and indication for implantation. The actuarial survival was not significantly different between groups 1 and 2 (P > 0.05; primary endpoint), with a 1-year survival of 91% and 93% in groups 1 and 2, respectively, (P = NS). The complication rates at the time of ICD implantation were similar in groups 1 and 2 (6.6% and 13.1%, respectively, P = 0.16). Age alone may not be sufficient criteria to exclude ICD implantation. The current consensus guidelines for ICD implantation appear to be generalizable to treating octogenarians who are otherwise medically fit.
KW - Feasibility
KW - ICD
KW - Implantable cardioverter defibrillator
KW - Octogenarians
KW - Safety
UR - http://www.scopus.com/inward/record.url?scp=1542506230&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=1542506230&partnerID=8YFLogxK
U2 - 10.1111/j.1540-8159.2004.00445.x
DO - 10.1111/j.1540-8159.2004.00445.x
M3 - Article
C2 - 15009867
AN - SCOPUS:1542506230
SN - 0147-8389
VL - 27
SP - 373
EP - 378
JO - PACE - Pacing and Clinical Electrophysiology
JF - PACE - Pacing and Clinical Electrophysiology
IS - 3
ER -